Haemonetics Corporation (HAE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Haemonetics Corporation, with annual and quarterly history.
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 26.20x | 18.97x | 36.57x | 36.41x | 74.40x | 70.81x |
| P/B Ratio | 3.20x | 3.87x | 4.48x | 5.14x | 4.31x | 7.69x |
| P/S Ratio | 1.91x | 2.34x | 3.28x | 3.60x | 3.25x | 6.46x |
| Profitability | ||||||
| Gross Margin | 55.7% | 57.2% | 54.4% | 53.3% | 53.4% | 49.2% |
| Operating Margin | 18.1% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% |
| Net Margin | 7.3% | 12.3% | 9.0% | 9.9% | 4.4% | 9.1% |
| EBITDA Margin | 29.8% | 26.2% | 22.6% | 21.6% | 19.3% | 21.2% |
| Liquidity | ||||||
| Current Ratio | 2.95x | 1.62x | 2.56x | 3.06x | 1.71x | 2.74x |
| Quick Ratio | 1.87x | 0.99x | 1.50x | 2.03x | 1.05x | 1.46x |
| Leverage | ||||||
| Debt/Equity | 1.54x | 1.49x | 0.84x | 0.94x | 1.04x | 1.06x |
YoY = year-over-year change. Source: FMP..